- Home
- ACIU vs ELMD Comparison
ACIU vs ELMD Comparison
Compare ACIU & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ELMD
- Stock Information
- Founded
- ACIU 2003
- ELMD 1992
- Country
- ACIU Switzerland
- ELMD United States
- Employees
- ACIU N/A
- ELMD N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACIU Health Care
- ELMD Health Care
- Exchange
- ACIU Nasdaq
- ELMD Nasdaq
- Market Cap
- ACIU 168.7M
- ELMD 190.6M
- IPO Year
- ACIU 2016
- ELMD 2010
- Fundamental
- Price
- ACIU $2.07
- ELMD $21.81
- Analyst Decision
- ACIU Strong Buy
- ELMD Strong Buy
- Analyst Count
- ACIU 1
- ELMD 1
- Target Price
- ACIU $12.00
- ELMD $38.00
- AVG Volume (30 Days)
- ACIU 119.1K
- ELMD 52.9K
- Earning Date
- ACIU 08-05-2025
- ELMD 05-13-2025
- Dividend Yield
- ACIU N/A
- ELMD N/A
- EPS Growth
- ACIU N/A
- ELMD 60.99
- EPS
- ACIU N/A
- ELMD 0.79
- Revenue
- ACIU $32,014,254.00
- ELMD $61,439,000.00
- Revenue This Year
- ACIU N/A
- ELMD $17.91
- Revenue Next Year
- ACIU $533.21
- ELMD $11.70
- P/E Ratio
- ACIU N/A
- ELMD $27.41
- Revenue Growth
- ACIU 91.20
- ELMD 14.85
- 52 Week Low
- ACIU $1.43
- ELMD $13.74
- 52 Week High
- ACIU $4.37
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- ACIU 59.88
- ELMD 59.39
- Support Level
- ACIU $1.79
- ELMD $20.00
- Resistance Level
- ACIU $2.10
- ELMD $20.39
- Average True Range (ATR)
- ACIU 0.17
- ELMD 0.64
- MACD
- ACIU 0.00
- ELMD 0.27
- Stochastic Oscillator
- ACIU 71.93
- ELMD 95.45
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.